← Open Payments lookup

SPENCER STODDARD: Open Payments

NPI 1417645193 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,953 in 118 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $657 · 2025 $1,953

Food & beverage: $1,953
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.19$377
Axsome Therapeutics, Inc.21$371
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$341
E.R. Squibb & Sons, L.L.C.20$266
JAZZ PHARMACEUTICALS INC.9$205
Alkermes, Inc.18$153
Supernus Pharmaceuticals, Inc.2$86
Janssen Pharmaceuticals, Inc4$64
Corium, LLC1$30
HARMONY BIOSCIENCES LLC1$17

Products named: CAPLYTA, Auvelity, COBENFY, REXULTI, XYWAV, ARISTADA, ABILIFY MAINTENA, Qelbree.

Industry payments across NE — which companies pay providers there.